Although VSIG4 expression is restricted in tissue-resident macrophages at a steady state, several studies have reported an upregulation of VSIG4 expression in lung cancer (93), breast cancer (94), ovarian cancer (95), and multiple myeloma (MM) (96). Here, VSIG4 is linked to lung cancer.